These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 2836181

  • 1. The 7-34-fragment of human hypercalcemia factor is a partial agonist/antagonist for parathyroid hormone-stimulated cAMP production.
    McKee RL, Goldman ME, Caulfield MP, DeHaven PA, Levy JJ, Nutt RF, Rosenblatt M.
    Endocrinology; 1988 Jun; 122(6):3008-10. PubMed ID: 2836181
    [Abstract] [Full Text] [Related]

  • 2. Treatment of bone-derived ROS 17/2.8 cells with dexamethasone and pertussis toxin enables detection of partial agonist activity for parathyroid hormone antagonists.
    McKee RL, Caulfield MP, Rosenblatt M.
    Endocrinology; 1990 Jul; 127(1):76-82. PubMed ID: 2163326
    [Abstract] [Full Text] [Related]

  • 3. Dissociation of cAMP accumulation and phosphate uptake in opossum kidney (OK) cells with parathyroid hormone (PTH) and parathyroid hormone related protein (PTHrP).
    Muff R, Caulfield MP, Fischer JA.
    Peptides; 1990 Jul; 11(5):945-9. PubMed ID: 2178252
    [Abstract] [Full Text] [Related]

  • 4. Removal of partial agonism from parathyroid hormone (PTH)-related protein-(7-34)NH2 by substitution of PTH amino acids at positions 10 and 11.
    Nutt RF, Caulfield MP, Levy JJ, Gibbons SW, Rosenblatt M, McKee RL.
    Endocrinology; 1990 Jul; 127(1):491-3. PubMed ID: 2163325
    [Abstract] [Full Text] [Related]

  • 5. A new highly potent parathyroid hormone antagonist: [D-Trp12,Tyr34]bPTH-(7-34)NH2.
    Goldman ME, McKee RL, Caulfield MP, Reagan JE, Levy JJ, Gay CT, DeHaven PA, Rosenblatt M, Chorev M.
    Endocrinology; 1988 Nov; 123(5):2597-9. PubMed ID: 2844517
    [Abstract] [Full Text] [Related]

  • 6. A tumor-secreted protein associated with human hypercalcemia of malignancy. Biology and molecular biology.
    Rosenblatt M, Caulfield MP, Fisher JE, Horiuchi N, Mckee RL, Rodan SB, Thiede MA, Thompson DD, Seedor JG, Nutt RE.
    Ann N Y Acad Sci; 1988 Nov; 548():137-45. PubMed ID: 2854715
    [Abstract] [Full Text] [Related]

  • 7. Direct action of the parathyroid hormone-like human hypercalcemic factor on bone.
    Thompson DD, Seedor JG, Fisher JE, Rosenblatt M, Rodan GA.
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5673-7. PubMed ID: 3399507
    [Abstract] [Full Text] [Related]

  • 8. Influence of the amino-terminus on in vitro and in vivo biological activity of synthetic parathyroid hormone-like peptides of malignancy.
    Rabbani SA, Mitchell J, Roy DR, Hendy GN, Goltzman D.
    Endocrinology; 1988 Dec; 123(6):2709-16. PubMed ID: 2848683
    [Abstract] [Full Text] [Related]

  • 9. Two species of adenylate cyclase-stimulating activity in a murine squamous carcinoma model of humoral hypercalcemia of malignancy.
    Burtis WJ, Broadus AE, Insogna KL, Weir EC, Stewart AF.
    Endocrinology; 1986 May; 118(5):1982-8. PubMed ID: 3009144
    [Abstract] [Full Text] [Related]

  • 10. Inhibition by (D-Trp12,Tyr34)bPTH(7-34)amide of PTH and PTHrP effects on Pi transport in renal cells.
    Pizurki L, Rizzoli R, Bonjour JP.
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F389-92. PubMed ID: 2167018
    [Abstract] [Full Text] [Related]

  • 11. The arterio-venous difference for immunoreactive parathyroid hormone and the production of adenosine 3,'5'-monophosphate by isolated perfused bone: studies with analogs of parathyroid hormone.
    Martin KJ, Bellorin-Font E, Freitag J, Rosenblatt M, Slatopolsky E.
    Endocrinology; 1981 Sep; 109(3):956-9. PubMed ID: 6266817
    [Abstract] [Full Text] [Related]

  • 12. Functional properties of a synthetic chicken parathyroid hormone-related protein 1-36 fragment.
    Schermer DT, Bradley MS, Bambino TH, Nissenson RA, Strewler GJ.
    J Bone Miner Res; 1994 Jul; 9(7):1041-6. PubMed ID: 7942150
    [Abstract] [Full Text] [Related]

  • 13. Human PTH-(3-34) inhibited the effects of human parathyroid hormone-related protein on phosphate uptake in a cultured renal cell line (OK cells).
    Nakai M, Fukase M, Yamaguchi T, Tsukamoto T, Fujii N, Fujita T.
    J Bone Miner Res; 1990 Oct; 5(10):995-1002. PubMed ID: 1964359
    [Abstract] [Full Text] [Related]

  • 14. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor.
    Behar V, Pines M, Nakamoto C, Greenberg Z, Bisello A, Stueckle SM, Bessalle R, Usdin TB, Chorev M, Rosenblatt M, Suva LJ.
    Endocrinology; 1996 Jul; 137(7):2748-57. PubMed ID: 8770894
    [Abstract] [Full Text] [Related]

  • 15. Evaluation in vivo of a potent parathyroid hormone antagonist: [Nle8,18,D-Trp12,Tyr34]bPTH(7-34)NH2.
    Dresner-Pollak R, Yang QM, Behar V, Nakamoto C, Chorev M, Rosenblatt M.
    J Bone Miner Res; 1996 Aug; 11(8):1061-5. PubMed ID: 8854241
    [Abstract] [Full Text] [Related]

  • 16. Synthetic peptides comprising the amino-terminal sequence of a parathyroid hormone-like protein from human malignancies. Binding to parathyroid hormone receptors and activation of adenylate cyclase in bone cells and kidney.
    Nissenson RA, Diep D, Strewler GJ.
    J Biol Chem; 1988 Sep 15; 263(26):12866-71. PubMed ID: 2843501
    [Abstract] [Full Text] [Related]

  • 17. Interspecies comparison of renal cortical receptors for parathyroid hormone and parathyroid hormone-related protein.
    Orloff JJ, Goumas D, Wu TL, Stewart AF.
    J Bone Miner Res; 1991 Mar 15; 6(3):279-87. PubMed ID: 1852088
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of fully active biotinylated analogues of parathyroid hormone and parathyroid hormone-related protein as tools for the characterization of parathyroid hormone receptors.
    Roubini E, Duong LT, Gibbons SW, Leu CT, Caulfield MP, Chorev M, Rosenblatt M.
    Biochemistry; 1992 Apr 28; 31(16):4026-33. PubMed ID: 1314656
    [Abstract] [Full Text] [Related]

  • 19. The bovine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor binding domains of PTH and PTH-related protein are located within the 14-34 region.
    Caulfield MP, McKee RL, Goldman ME, Duong LT, Fisher JE, Gay CT, DeHaven PA, Levy JJ, Roubini E, Nutt RF.
    Endocrinology; 1990 Jul 28; 127(1):83-7. PubMed ID: 2163327
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of in vitro bone resorption by a parathyroid hormone receptor antagonist in the canine adenocarcinoma model of humoral hypercalcemia of malignancy.
    Rosol TJ, Capen CC.
    Endocrinology; 1988 May 28; 122(5):2098-102. PubMed ID: 2834184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.